Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator A Science Advisory From the American Heart Association/American Stroke Association

被引：606

作者：

del Zoppo, Gregory J.

Saver, Jeffrey L.

Jauch, Edward C.

Adams, Harold P., Jr.

机构：

来源：

STROKE | 2009年 / 40卷 / 08期

关键词：

AHA Scientific Statements; stroke; tissue plasminogen activator; hemorrhage; intracerebral hemorrhage; DOUBLE-BLIND; ALTEPLASE; THROMBOLYSIS; ATLANTIS; TRIAL; ECASS;

D O I：

10.1161/STROKEAHA.109.192535

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：2945 / 2948

页数：4

共 16 条

[1] Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and intervention council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups (vol 38, pg 1655, 2007) [J].

Adams .

STROKE, 2007, 38 (06) :E38-E38

[2]

Adams, 2007, STROKE, V38, pE96

[3] Guidelines for the early management of adults with ischemic stroke - A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups [J].

Adams, Harold P., Jr. ;

del Zoppo, Gregory ;

Alberts, Mark J. ;

Bhatt, Deepak L. ;

Brass, Lawrence ;

Furlan, Anthony ;

Grubb, Robert L. ;

Higashida, Randall T. ;

Jauch, Edward C. ;

Kidwell, Chelsea ;

Lyden, Patrick D. ;

Morgenstern, Lewis B. ;

Qureshi, Adnan I. ;

Rosenwasser, Robert H. ;

Scott, Phillip A. ;

Wijdicks, Eelco F. M. .

STROKE, 2007, 38 (05) :1655-1711

[4]

[Anonymous], 1993, THROMBOLYTIC THERAPY

[5] Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset - The ATLANTIS study: A randomized controlled trial [J].

Clark, WM ;

Wissman, S ;

Albers, GW ;

Jhamandas, JH ;

Madden, KP ;

Hamilton, S .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2019-2026

[6] The rtPA (Alteplase) 0-to 6-hour acute stroke trial, part A (A0276g) - Results of a double-blind, placebo-controlled, multicenter study [J].

Clark, WM ;

Albers, GW ;

Madden, KP ;

Hamilton, S .

STROKE, 2000, 31 (04) :811-816

[7] RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE THROMBOTIC AND EMBOLIC STROKE [J].

DELZOPPO, GJ ;

POECK, K ;

PESSIN, MS ;

WOLPERT, SM ;

FURLAN, AJ ;

FERBERT, A ;

ALBERTS, MJ ;

ZIVIN, JA ;

WECHSLER, L ;

BUSSE, O ;

GREENLEE, R ;

BRASS, L ;

MOHR, JP ;

FELDMANN, E ;

HACKE, W ;

KASE, CS ;

BILLER, J ;

GRESS, D ;

OTIS, SM .

ANNALS OF NEUROLOGY, 1992, 32 (01) :78-86

[8] Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) [J].

Hacke, W ;

Kaste, M ;

Fieschi, C ;

von Kummer, R ;

Davalos, A ;

Meier, D ;

Larrue, V ;

Bluhmki, E ;

Davis, S ;

Donnan, G ;

Schneider, D ;

Diez-Tejedor, E ;

Trouillas, P .

LANCET, 1998, 352 (9136) :1245-1251

[9]

HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017

[10]

Hacke W, 2004, LANCET, V363, P768

← 1 2 →